Compelling evidence indicates that Wnt10B may be a valuable therapeutic target for TNBC, and a transgenic murine model with a Wnt10B-driven tumor is shown to have characteristics of human TNBC [52]. The gene discussed is WNT10B; the disease is neoplasm.